Kanova
About:
Kanova is a biopharmaceutical firm that focuses on developing therapeutic antibodies to treat cancer and autoimmune diseases.
Website: http://en.kanovabiopharma.com
Top Investors: Northern Light Venture Capital, BioVenture, CD Capital, Sino-Singapore Capital, ShenZhen GTJA Investment Group
Description:
Kanova is a biopharmaceutical company that focuses on developing therapeutic antibodies and innovative combination therapies in immuno-oncology and autoimmune diseases.
Total Funding Amount:
215M CNY
Headquarters Location:
Suzhou, Jiangsu, China
Founded Date:
2015-11-01
Contact Email:
hr(AT)kanovabiopharma.com
Founders:
Chen Dong
Number of Employees:
1-10
Last Funding Date:
2023-07-25
IPO Status:
Private
Industries:
© 2025 bioDAO.ai